FilingIndex
← The Wire
CRLNYSE

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Services-Commercial Physical & Biological Research · CIK 1100682

Charles River Laboratories provides drug discovery and development products and services to pharmaceutical and biotechnology companies

red 8-K · 90d🔥 High media attention
$9.03B
Market cap
$225.57
Last close
+4.5%
1D
+24.2%
5D
1.1M
Volume
Price · last 39 sessions+30.9%
May 4L $149.93 · H $225.57Jun 29
170
Total filings
May 11, 2026
Last filing
12/27
Fiscal year end
8-KExecutive Change · Shareholder VoteMay 11, 202610-Q10-QMay 7, 20268-KResults of OperationsMay 7, 2026DEF 14ADEF 14AMar 31, 20268-KReg FD DisclosureFeb 25, 20268-KExecutive ChangeFeb 18, 202610-K10-KFeb 18, 20268-KResults of OperationsFeb 18, 20268-KResults of Operations · Reg FD DisclosureJan 13, 20268-KExecutive ChangeJan 9, 20268-KReg FD DisclosureDec 3, 20258-KCompany UpdateNov 17, 202510-Q10-QNov 5, 20258-KResults of OperationsNov 5, 20258-K/AExecutive ChangeSep 19, 20258-KExecutive Change · Reg FD DisclosureSep 16, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KExecutive Change · Shareholder VoteMay 23, 202510-Q10-QMay 7, 20258-KExecutive Change · Material AgreementMay 7, 20258-KResults of OperationsMay 7, 2025DEF 14ADEF 14AApr 2, 20258-KCompany UpdateFeb 21, 202510-K10-KFeb 19, 20258-KResults of OperationsFeb 19, 20258-KReg FD DisclosureJan 14, 20258-KNew Debt / ObligationDec 13, 2024SC 13GSEC SCHEDULE 13GNov 8, 202410-Q10-QNov 6, 20248-KResults of OperationsNov 6, 202410-Q10-QAug 7, 20248-KResults of OperationsAug 7, 20248-KShareholder VoteMay 10, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 2024DEFA14AFORM DEFA14AApr 24, 2024DEF 14AFORM DEF 14AMar 29, 202410-K10-KFeb 14, 20248-KResults of OperationsFeb 14, 20248-KExecutive ChangeJan 24, 20248-KExecutive ChangeJan 16, 20248-KCompany UpdateNov 15, 202310-Q10-QNov 8, 20238-KResults of OperationsNov 8, 202310-Q10-QAug 9, 20238-KResults of OperationsAug 9, 20238-KShareholder VoteMay 15, 202310-Q10-QMay 11, 20238-KResults of OperationsMay 11, 2023DEFA14AFORM DEFA14AMay 1, 2023DEF 14ADEF 14AMar 30, 202310-K10-KFeb 22, 20238-KResults of OperationsFeb 22, 20238-KExecutive ChangeDec 6, 20228-KReg FD DisclosureNov 30, 202210-Q10-QNov 2, 20228-KResults of OperationsNov 2, 202210-Q10-QAug 3, 20228-KResults of OperationsAug 3, 20228-KReg FD DisclosureJun 8, 20228-KShareholder VoteMay 12, 202210-Q10-QMay 4, 20228-KResults of OperationsMay 4, 2022DEFA14AFORM DEFA14AApr 25, 2022DEF 14ADEF 14AMar 30, 20228-KExecutive ChangeMar 28, 202210-K10-KFeb 16, 20228-KResults of OperationsFeb 16, 2022SC 13GSC 13GFeb 9, 20228-KExecutive Change · Reg FD DisclosureJan 11, 20228-KExecutive ChangeDec 27, 20218-KBylaw AmendmentDec 15, 20218-KExecutive ChangeNov 12, 20218-KReg FD DisclosureNov 9, 202110-Q10-QNov 3, 20218-KResults of OperationsNov 3, 202110-Q10-QAug 4, 20218-KResults of OperationsAug 4, 20218-KExecutive ChangeMay 18, 2021

Insider Activity

In the 90 days to Mar 3, 2026: 1 insider bought $4K.

DateInsiderActionSharesPriceValue
Mar 3, 2026Laplume Joseph WEVP, Corp Strategy & DevelopBuy25$174.54$4K
Aug 22, 2025Laplume Joseph WEVP, Corp Strategy & DevelopSell400$163.72$65K

Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.

Similar companies

Comparable business profile · signals at a glance